ABSTRACT The therapeutic potential of elastin-like polypeptide (ELP) conjugated to therapeutic compounds is currently being investigated as an approach to target drugs to solid tumors. ELPs are hydrophobic polymers that are soluble at low temperatures and cooperatively aggregate above a transition temperature (T T ), allowing for thermal targeting of covalently attached drugs. They have been shown to cooperatively transition from a disordered structure to a repeating type II b-turn structure, forming a b-spiral above the T T . Here we present biophysical measurements of the structural, thermodynamic, and hydrodynamic properties of a specific ELP being investigated for drug delivery, ELP[V 5 G 3 A 2 -150]. We examine the biophysical properties below and above the T T to understand and predict the therapeutic potential of ELP-drug conjugates. We observed that below the T T , ELP[V 5 G 3 A 2 -150] is soluble, with an extended conformation consisting of both random coil and heterogeneous b structures. Sedimentation velocity experiments indicate that ELP[V 5 G 3 A 2 -150] undergoes weak self-association with increasing temperature, and above the T T the hydrophobic effect drives aggregation entropically. These experiments also reveal a previously unreported temperature-dependent critical concentration (Cc) that resembles a solubility constant. Labeling ELP[V 5 G 3 A 2 -150] with fluorescein lowers the T T by 3.5 C at 20 mM, whereas ELP[V 5 G 3 A 2 -150] dissolution in physiological media (fetal bovine serum) increases the T T by~2.2 C.
INTRODUCTION
Elastin-like polypeptides (ELPs) are thermoresponsive biopolymers that consist of repeating pentapeptide sequences of the amino acids Val-Pro-Gly-Xaa-Gly (VPGXG, where X can be any common amino acid other than proline). Below the transition temperature (T T ), ELPs are soluble in aqueous solutions and assumed to be monomeric, but above the T T , ELPs desolvate and hydrophobic interactions promote the formation of what is widely reported to be a b-spiral conformation that is coupled to aggregation (1) . This aggregation process is physically similar to a phase change and the T T is sometimes referred to in the literature as a lower critical solution temperature (1) . The T T of an ELP is a concentration-dependent parameter that is unique to each polymer and inversely related to the concentration, number of monomer repeats, and hydrophobicity of the fourth or variable X residue of the pentapeptide repeat (2) (3) (4) (5) . Because of the dependence of the T T on physical properties that can be manipulated by altering the X composition, new ELPs can be rationally designed with any desired T T . An excellent summary of engineering an ELP with a precise T T can be found in Chilkoti et al. (3) .
Many novel ELPs have been designed and a nomenclature has been developed (3) so that any ELP can be described by ELP[X # X # X # À n], where X represents guest residues in the pentapeptide, # is the number of pentapeptide repeats with that residue, the sum of the #s gives the number of pentapeptides within a repeating monomer unit, and n represents the total number of pentapeptide repeats in the overall protein.
To illustrate the nomenclature using the ELP peptide under study, ELP[V 5 G 3 A 2 -150] is a polymer with a repeating monomer unit consisting of three different pentapeptides (VPGVG, VPGGG, and VPGAG, in a ratio of 5:3:2, respectively (Table 1) ). The repeating monomer has a total of 10 pentapeptide blocks, and the total length of the ELP [V 5 G 3 A 2 -150] polymer is comprised of 15 monomer units, totaling 150 pentapeptide repeats (or 750 amino acid residues). There is also an MSKGPG sequence at the N-terminal region, with the lysine engineered for drug attachment, and a WP capping sequence at the C-terminal end (see Table 1 ).
Any small molecules or peptide therapeutics can be chemically conjugated to ELP and delivered systemically. At physiological temperatures, the ELP-drug conjugate is soluble and is believed to circulate as monomers (3, (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . When a specific area, such as a tumor, is heated through high-intensity focused ultrasound, radiofrequency, or microwaves, the ELP will aggregate and localize the drug to the site of heating (3) . Cellular uptake of localized ELP is facilitated by N-terminal attachment of a cell-penetrating peptide (CPP) that stimulates endocytosis (6) . Among the peptides previously conjugated to ELP[V 5 G 3 A 2 -150] and used for delivery in cell and animal models by Raucher and co-workers are the GRG peptide (7), p21 peptide (8, 9) , c-Myc peptide (10) (11) (12) (13) , and L12 peptide (14) . ELP[V 5 G 3 A 2 -150] has also been conjugated to a number of small-molecule drugs, including doxorubicin (15, 16) and Paclitaxel (17) . These studies have demonstrated the ability of ELP[V 5 G 3 A 2 -150] to increase the targeting and efficacy of systemically delivered therapeutics relative to free therapeutics.
The structural changes and thermodynamic properties of ELP aggregation at high temperature have been explored for ELPs of different lengths and guest residue compositions similar to that of ELP[V 5 G 3 A 2 -150] (4, 5) . However, the hydrodynamic and solution properties of ELP constructs have not been previously investigated. Hydrodynamic analysis is crucial for therapeutic development (and often required by the U.S. Food and Drug Administration) because it is uniquely suited to describing solution behavior. Several questions remain to be addressed: 1), is the therapeutic construct monomeric or does it self-associate below the T T ; 2), does the therapeutic construct interact with plasma proteins; and 3), is the T T for ELP[V 5 G 3 A 2 -150] affected by the macromolecular crowding present in physiological media such as fetal bovine serum (FBS)?
In this study we investigated the structural, thermodynamic, and hydrodynamic properties of ELP[V 5 G 3 A 2 -150] over a range of temperatures below and above the T T , with the goal of understanding how ELP[V 5 G 3 A 2 -150] behaves both in PBS and in physiological buffer. We analyzed the T T of ELP[V 5 G 3 A 2 -150] as a function of temperature using turbidity. The size and size distribution were determined at temperatures ranging from below the T T to above the T T using dynamic light scattering (DLS). The enthalpy change for the aggregation reaction was determined using differential scanning calorimetry (DSC) and the secondary structure was investigated using circular dichroism (CD). Analytical ultracentrifugation (AUC; specifically, sedimentation velocity (SV) experiments) was used to determine the hydrodynamic properties of ELP[V 5 G 3 A 2 -150].
MATERIALS AND METHODS
Information regarding the materials and methods used in this study is provided in the Supporting Material.
RESULTS

Sequence analysis
The ELP under study (ELP[V 5 G 3 A 2 -150]) is a 758 residue polypeptide with a molecular mass of 59,546.61 Da (Table 1) . It is predicted by the software utility PONDR (18) (19) (20) to be highly disordered throughout its entire sequence, with an average disorder prediction of 0.9902 (Table 1). This is to be expected given the high proline content. This prediction of disorder is consistent with the prevailing view of ELPs as intrinsically disordered proteins (IDPs) below the T T . ELP[V 5 G 3 A 2 -150] contains 15 repeating units of 10 pentapeptide residues with a mean hydrophobicity <H> of 0.589 (21) . IDPs are often grouped according to how compact they are in solution, and it is believed that ELP adopts an extended conformation in solution (1, (3) (4) (5) 
where N is the total number of residues, and R 0 and v are constants determined by Wilkins et al. (22) 
where Q is the charge; P ¼ fraction prolines; S His ¼ 1 since no histidine tag is present; and A, B, C, D, R o , and v are con- (Table 1) . This result for the folded state is in agreement with an estimate for a typical folded protein with the same molecular weight as ELP assuming a frictional ratio f/f 0 of 1.2, R S ¼ 3.2 nm.
Examination of the T T of ELP[V 5 G 3 A 2 -150]
The T T is the concentration-dependent temperature at which an ELP will aggregate and thus localize systemically delivered therapeutics. We determined the T T for ELP Average disorder is defined by averaging the predicted disorder over the entire polypeptide, where 0 indicates a high probability of order and 1 a high probability of disorder. <H> is the mean hydrophobicity of the polypeptide. R H D is the predicted hydrodynamic radius of a completely disordered protein with a high proline content of the same residue number. R H F is the predicted hydrodynamic radius of a globular protein of the same residue number. The repeating 10-pentapeptide sequence of ELP is presented in a condensed format by showing the composition of 10 sequential pentaptide repeats (VPG[X]G), where the identity of each guest residue, X, is presented in brackets.
Biophysical Journal 104(9) 2009-2021 [V 5 G 3 A 2 -150] by measuring the turbidity in PBS as a function of temperature. The turbidity remained constant at low temperatures until a sharp and cooperative increase occurred at the T T (Fig. 1 A) . We examined the reversibility of the ELP[V 5 G 3 A 2 -150] aggregation process by repeatedly heating and cooling a solution of ELP[V 5 G 3 A 2 -150] (Fig. 1 A) . (The reversibility was measured at 1.0 C/min and could not be measured at a slower heating rate (e.g., 0.1 C/min) because the aggregates formed would slowly pellet to the bottom of the cuvette from the force of gravity. Even if they were mixed, the hysteresis would persist because aggregation and resolubilization occur at different rates. The T T was measured at 0.1 C/min to improve overlap among the turbidity, DLS, and DSC data (see below).)
The overlay of the heating and cooling profiles indicates that the aggregation process is both reversible and repeatable. A hysteresis between the aggregation and disassembly profiles suggests a difference in the kinetics of the two processes. The T T was measured as a function of concentration of ELP[V 5 G 3 A 2 -150] and an inverse relationship was observed between ELP[V 5 G 3 A 2 -150] concentration and the T T ( Fig. 1 B, open triangles) . The inverse dependence of T T on concentration was previously measured for other ELPs (2) and determined to be a linear function when plotted on a log scale according to
where T T 0 is the extrapolated T T at infinite dilution. This was measured for ELP [V 5 (Fig. 1 B) .
Examination of the change in size and heat capacity during the aggregation process Because the DLS measurement is done at the bottom of the cell and the turbidity measurements are done in the middle of the cuvette, the change in aggregate concentration with time results in the differences in the high-temperature data. In other words, the turbidity measurements initially reflect a homogeneous distribution of large particles distributed throughout the cell, but as the particles aggregate and precipitate, the turbidity measurements reflect the concentration of the particles left in the supernatant. Due to cell design differences, this effect is attenuated in the DLS cell, but in fact at higher temperature or longer times, even the DLS data show some decrease in the particle size distribution.) The enthalpy change for the phase transition was measured using DSC (Fig. 2) , and the DH values are reported in Table 2 . The positive enthalpy change of 46 kcal/mol (192 kJ/mol) indicates that the phase transition is an endothermic process, consistent with processes involving the desolvation of the polymer coupled to the aggregation. Interchain interactions (e.g., weak van der Waals interactions) would yield a small exothermic contribution to the overall transition enthalpy change. ELP transition enthalpy changes reported in the literature vary widely from as low as 34 kJ/mol (24) to >800 kJ/ mol (25) (26) (27) Table 2 ).
Examination of the polypeptide secondary structure below and above the T T To elucidate the structural changes that accompany the aggregation process, we examined the secondary structure using CD over a range of temperatures below and above the T T (Fig. 3, A-C) . The shape of the CD spectra obtained as a function of temperature is consistent with previous results obtained on ELP constructs by four different research groups (28) (29) (30) (31) , with a temperature-dependent minimum at 195 nm, a temperature-dependent maximum at 210 nm, and a temperature-independent minimum at 225 nm. The CD spectrum for an ELP was first interpreted by Urry et al. (29) , who determined that the minimum at 195 nm was caused by a random or disordered polypeptide structure, and that the maximum at 210 nm above the T T was caused by a repeating type II b-turn structure forming a b-spiral. This analysis was supported by Reiersen et al. (30) . Nicolini et al. (28) , however, analyzed the spectra to indicate a mixture of both random and b-turns/strands that changed in relative percentages with increasing temperature. Their analysis indicated that the minimum at 225 nm, present both below and above the T T , was caused by type II b-turns; however, the variation observed in b-sheet structures (e.g. antiparallel, parallel, mixed, intra-/intermolecular, and degree of twisting) makes it impossible to rule out some form of b-sheets (32) .
The sudden increase in the turbidity, DLS, and DSC data at the T T suggested a cooperative association model in which ELP[V 5 G 3 A 2 -150] sharply transitions from a soluble state to a fully aggregated and insoluble state. This sudden and cooperative transition of ELP[V 5 G 3 A 2 -150] from soluble monomer to insoluble aggregate is widely reported in the literature (2) . However, the decreasing magnitude of the minima at 195 nm in the CD spectra with increasing temperature, and the gradual change in the percentage of disordered structure also suggest that ELP[V 5 G 3 A 2 -150] exists in an equilibrium between monomer and a structure that shifts toward aggregate with increasing temperature. In fact, Urry et al. (29) noted that the signal was less than would be expected for a fully disordered structure. An equilibrium below T T is also supported by the molecular-dynamics simulations conducted by Baer et al. (28) R H is the hydrodynamic radius measured by DLS. R H T<T T is the hydrodynamic radius measured at the temperature immediately below the T T and thus is concentration dependent. Note that measuring particle sizes in the micrometer range would require static light scattering measurements taken over~10 hr. Therefore, the R H T>T T size measurements are estimates of the true size above the T T . The DLS measurements use an autocorrelation function to obtain the distribution of particle sizes present in a sample. The precision of the reported DLS measurements is the result of making replicate measurements and reporting the average value for the mean of the size distributions.
Biophysical Journal 104 (9) (Fig. 5 A) . At 5 C the S 20,W decreases with increasing concentration. This inverse relationship is explained by hydrodynamic nonideality K s , an empirical term that is in part a function of how extended the molecule is in solution and therefore how much frictional force (f) the solvent exerts on the molecule as it sediments. (The primary charge effect (36) also contributes to this slope in low-salt buffers; however, ELP has a very small charge (þ1) under these conditions.)
where f 0 is the frictional coefficient extrapolated to zero concentration. As the concentration of ELP[V 5 G 3 A 2 -150] increases, the sedimentation coefficient decreases according to (37) ,W can be used to calculate the frictional ratio (f/f 0 ), which is a measure of how extended a molecule is relative to a spherical particle of the same mass. At 5 C, f/f 0 ¼ 2.62 (Table 3) , indicating an extended conformation (for a globular hydrated protein, f/f 0 ¼~1.2), consistent with the low-temperature CD data. The R H calculated from the f/f 0 is 6.92 nm, which is very similar to the R H measured from the low-temperature DLS data (6.77-6.95 nm; Fig. 2 , summarized in Table 2 ). To verify that the 5 C SV data correspond to a nonideal monomer, the six experimental data sets were analyzed globally by Sedanal direct boundary fitting (40) , revealing random residuals and a best fit consist with monomeric ELP (Fig. S2) .
As the temperature is increased, the observed hydrodynamic nonideality (the slope of a 1/s versus c plot; Fig. 5 A) decreases until at 35 C there is no observable apparent nonideality. This is more apparent in the family of normalized g(s*) curves (Fig. 4) , where a nonideal or centripetal shift occurs with increasing concentration at low temperatures and an apparent nonassociating or weak centrifugal shift occurs at high temperatures. This could be attributed to compaction of ELP[V 5 G 3 A 2 -150] with increasing temperature. However, the R H measured by DLS increases with temperature below the T T , which is not consistent with compaction. In addition, although the f/f 0 does decrease slightly with temperature (from 2.62 to 2.33), it still indicates an extended conformation. Therefore, the temperature-dependent decrease observed in the apparent nonideality (K s ; Table 3 ) and the increase in R H measured by DLS can best be interpreted as weak association below the T T .
To better understand the effects of weak association on a nonideal system, we performed a series of SV simulations of a nonideal monomer-dimer system. The goal of the simulations was to test the hypothesis that weak association would cause a proportional decrease in the observed inverse concentration dependence of the S 20,W and therefore mask the nonideality of the system. The simulations assumed experimental conditions and a constant K s (mL/mg) value for both FIGURE 4 Normalized g(s*) summary of SV data collected at each temperature and multiple concentrations. The decrease in the boundary position with increasing concentration is caused by hydrodynamic nonideality, K s , a measure of excluded volume. This trend in the data is reduced at higher temperatures, and by [35] [36] [37] C the boundaries are shifting to higher S-values consistent with self-association. As discussed in the text, this self-association is hidden by the nonideality throughout the temperature range and requires constraining K s and BM1 to determine the magnitude of indefinite association K (M À1 monomer and dimer. A family of data sets was generated as a function of concentration and over a range of association constants. These data sets were analyzed by DCDTþ to generate g(s*) and to extract weight average S values, which are plotted as 1/S 20,w versus concentration (Fig. 5 B) . The simulated data (Fig. 5 B) exhibit the expected increase in apparent S with increasing association, and the data obtained at K 2 ¼ 10 4 M À1 are most consistent with the 30 C experimental data. The simulated data also exhibit a change in the extrapolated S 20,W values consistent with a higher extent of dimer present with larger K 2 values, although at the higher K 2 values the association is dominant over the nonideality and thus the slope is not decreasing. The model assumes no change in the f/f 0 , and thus the increase in the observed S 0 20,W in the simulations indicates that association will affect not only the concentration dependence but also the apparent f/f 0 . This suggests that the change in S 0 20,W seen in the experimental data may also be attributed to weak association and, consistent with the DLS data collected, need not be due to a compaction of the polypeptide.
A recent method developed by Rowe (39) to examine weak association is to plot the ratio of S 20,W /S 0 20,W as a function of concentration. Plotting the ratio emphasizes the effects of weak, concentration-dependent behavior (nonideality and self-association) by normalizing sedimentation C and high concentration exceeds that expected for a dimer, indicating that association beyond dimer is occurring. Finally, the extrapolated values increase at each temperature; however, the increase is far less than that seen in the simulated data, where K 2 approaches 10 6 M À1 . This analysis by the Rowe method thus suggests that the appropriate fitting model for the high temperature SV data sets is weak association (~10 4 M À1 ) that extends beyond dimer. To quantify the extent and strength of the association, we analyzed the raw SV data from each temperature globally by Sedanal direct boundary fitting to a series of stepwise association models (Table 4) . This is consistent with the Rowe method analysis applied above and explores the possibility that a discrete species serves as a nucleus. We obtained reasonably good fits (Table 4) by fitting the 10 C and 20 C data to a nonideal monomer-dimer model, the 30 C data to a monomer-dimer-trimer model, and the 35 C data to a monomer up to pentamer model. This series of best fits suggests that the extent of association may not be limited in size, but rather may increase indefinitely. Consequently, the fits were repeated with a model that assumed weak, indefinite association (40) . This model fits the various data sets much better, as indicated by root mean-square deviation (RMSD) values of 0.006-0.009 (Table 4) , which demonstrate that a nonideal indefinite polymerizing model best describes the data. The presence of weak association seen in the SV data and the increasing percentage of b-structure below the T T in the CD data suggest that loss of disorder, or gain of structure, with increasing temperature is coupled to the self-association of ELP.
When SV was performed at or above the T T , the ELP [V 5 G 3 A 2 -150] aggregated and pelleted at 1 K rpm, leaving behind a constant concentration that sedimented at the same S 20,W observed at 30 C and 35 C. This critical concentration (C C ) decreased as the temperature increased (Table S1) , consistent with an entropically driven polymerization process. The Cc is consistent within experimental error with the concentration at which ELP[V 5 G 3 A 2 -150] will aggregate by turbidity measurements at specific temperatures (solid squares in Fig. 1 B; inflection points in Fig. 2 ). This indicates that ELP[V 5 G 3 A 2 -150] does not fully aggregate at a specific temperature, but associates until the Cc for that temperature is reached. This suggests that although the aggregation process is cooperative, it might be appropriate to also describe the process as a solubility constant that is temperature dependent. The T T description accurately described the model of ELP[V 5 G 3 A 2 -150] transitioning from a disordered, completely soluble phase to an ordered, insoluble phase at a specific temperature. However, the Cc observed in SV indicates that ELP[V 5 G 3 A 2 -150] also Results from globally fitting raw SV data at each temperature to association models. The best-fit values from 5 C (K s ¼ 0.061 and BM1 ¼ 0.1714) were held constant for each fit, and the extent and strength of association were floated. The apparent s 1 value was held constant at the 5 C value, determined from the extrapolated data in Fig. 5 A, but corrected for temperature in the other data sets. Note that these values do not correspond to the extrapolated values, which include the effects of association as discussed in Fig. 5 . The s n was assumed to increase according to s 1 n 2/3 , which may underestimate the values of K (40). For each fit, the K was fixed to be constant for each step of polymerization (e.g., K 2 ¼ K 3 etc.). The same parameters were used for the indefinite, isodesmic fits; however, the extent of association was not restricted.
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exists in a temperature-dependent equilibrium between these two phases. The analysis of the CD spectra also suggests that a cooperative, structural transition does not explain the aggregation of ELP[V 5 G 3 A 2 -150], but rather an equilibrium where the relative amount of order increases. This equilibrium between two phases is accurately described by a solubility constant and a phase diagram (41). It is not clear whether a minimum size aggregate or a distribution of aggregate sizes, i.e., a nucleus, is required to initiate the phase transition at T T .
Turbidity and hydrodynamic analysis in FBS
The T T of ELP[V 5 G 3 A 2 -150] constructs designed for drug delivery is usually measured in either PBS or cell culture media (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . We measured the reversibility of thermal aggregation, the T T , and the hydrodynamic properties in FBS as an alternative to human serum, to determine how the system would behave in the physiological environment.
We found the thermal aggregation of ELP[V 5 G 3 A 2 -150] in 95% FBS to be completely reversible, consistent with the behavior in PBS (Fig. 6 A) (Fig. 1 B) , and the slope of the T T as a function of concentration is increased. This increase in the T T (Fig. S5 B) that was attributed to the Johnston-Ogston (J-O) effect (43) (44) (45) (46) . The J-O effect is due to the nonideality or molecular crowding serum proteins exhibit on slower-sedimenting species like ELP. The slowly sedimenting species build up during the run into a boundary that sharpens due to a faster sedimentation rate above the serum interface, and that continues to grow as more material is forced behind during the run. Analysis of this data by DCDT þ and Sedfit revealed that the boundary apparently runs significantly more slowly than ELP in PBS, in part due to the increased density and viscosity of serum. We attempted to calibrate the data by varying the percentage of FBS (Fig. 6 B) and performing SV experiments at 20 C and 30 C. The extrapolated values agree with the S o values measured in PBS and suggest that ELP does not form tight complexes in serum that alter its rate of sedimentation significantly. We cannot exclude weak complex formation that does not significantly alter the sedimentation rate. We also note that the slope of the lines at 20 C and 30 C vary in the same temperature-dependent manner as the data obtained in PBS (Fig. 5 A) , suggesting that the ELP is associating in serum, with itself or serum components, and masking the nonideality. Note that in this case, the nonideality is a cross-term effect due to the serum concentration. As described above, the turbidity data obtained in FBS demonstrate a higher T T than that obtained in PBS, which implies some favorable interaction with monomeric ELP that disfavors aggregation. Separate experiments indicated that ELP[V 5 G 3 A 2 -150] and most likely other ELP constructs exhibit weak attraction to g-globulins. This interaction, and possibly other weak interactions with less ubiquitous serum proteins, may account for the increase in the T T in serum. These data will be presented in a separate publication focusing on the J-O effect in FBS. Alternatively, changes in hydration or binding of other small serum components may contribute to this effect on T T . Future turbidity and sedimentation experiments with osmolytes will explore these possibilities.
DISCUSSION
ELP is a genetically engineered thermoresponsive biopolymer that is currently being studied as a means of targeting systemically delivered therapeutics in vivo. We measured the structural, thermodynamic, and hydrodynamic properties of ELP[V 5 G 3 A 2 -150], a specific ELP that is being investigated for drug delivery in cancer model systems, including cell culture and xenografts in mice. The DLS, DSC, and turbidity T T data coincide and agree with a cooperative aggregation process that involves the release of water, as indicated by a large positive DH value. The transition is coupled to formation of b-turn structures throughout the temperature range below T T , as indicated by the loss of random coil and the gain of b-turn structures in the CD data. This transition is concentration dependent, suggesting a gradual temperature-dependent association process that is coupled to conformational changes. This conclusion is supported by the AUC data, which reveal a nonideal, weak, indefinite self-association that is nonetheless significant at the concentrations being investigated both in the biophysical measurements and in the therapeutic experiments. The AUC data also reveal a Cc below which no phase change or aggregation occurs. This equates the T T or the Cc to a solubility concentration, consistent with the phase change being a coaservate process in which there is an equilibrium between phases. The large size of the aggregates as measured by DLS support this interpretation. Although much of this is consistent with the literature on ELPs, there are some new features worth discussing.
The measurement of the R H by DLS allows us to calculate the compaction index (CI) of ELP[V 5 G 3 A 2 -150], or the degree of compaction relative to globular versus denatured proteins, by comparing the measured R H with the R H calculated for an unfolded versus a folded protein of the same size. The CI is presented on a scale of 0 to 1, with 0 indicating a fully extended conformation and 1 indicating a globular or highly compact conformation. We use the method presented by Brocca et al. (47) , who defined the CI as (23) . Thus, AUC offers a significant advantage in measuring f/f 0 and R H values because it can reveal the presence of association, which might also be linked to folding, compaction, and function. A concerted effort to measure SV data on a large number of IDPs as a function of temperature and concentration might be useful to demonstrate the utility of this perspective.
The models for Sedanal fitting of SV data were constructed with four assumptions: 1) At 5 C, no appreciable association occurs, and therefore any change in the system above 5
C is caused by temperature-induced association. This is justified by the fact that these data are best fit by direct boundary analysis to a nonideal monomeric system with the correct molecular weight of ELP[V 5 G 3 A 2 -150] (Fig. S2) . This is also supported by the CD and DLS data. 2) No change in the shape (f/f 0 ) of ELP[V 5 G 3 A 2 -150] occurs with increasing temperature. The SV simulations suggest that the decrease in the apparent calculated f/f 0 can be attributed to association, not a change in shape. Therefore, the s n value of higher-order species was assumed to increase according to a traditional n 2/3 model, implying that the oligomers maintain a similar extended shape like the monomers (40) . This is supported by the R H values seen in the DLS data at 5 C ( Fig. 2 and Table 2 ).
3) The nonideality or K s of higher-order species remains constant on a weight basis. This is a common assumption in the field in the absence of molecular information about the shapes of dimers, trimers, etc. (48, 49) . For globular proteins this is a reasonable starting point, based on empirical observations of the nonideality of BSA and g-globulin dimers remaining constant relative to monomer (data not shown). To adjust this, we would need a molecular model as the basis for bead modeling (40). 4) Finally, the stepwise association models assumed a constant K for each step but limited the maximum nmer values to estimate an extent of association. The isodesmic association model proved to be the best model and assumed a constant K for each step, K iso , but did not limit the maximum size of oligomers included in the fit. For an isodesmic model, higher oligomers are necessarily less populated on a molar basis due to this constant K assumption.
The analysis of weakly nonideal associating systems is intrinsically difficult because K s and K iso values numerically couple in the fitting procedures, and because one must collect the data at higher concentrations to observe the association, nonideality will be significant. Thus, if we allowed the 5 C nonideality values to float while fitting K iso rather than constraining them, significant changes to the Biophysical Journal 104 (9) 2009-2021 association parameters at higher temperatures would occur. In addition, the s n values, the sedimentation coefficient of the nth oligomer, are calculated assuming an n 2/3 relationship, as well as an assumption about constant shape. As previously discussed (40) , a more realistic assumption about an extended shape would lower the s n values and thus raise the K iso values. For example, if R H varies as N .285 (Eqs. 1 and 2), the relationship between s 1 and s n might drop to n 1/3 and K iso would increase by 2-to 4-fold (~À0.6 kcal/mol), although the RMSDs of the fits are not as good as those for the n 2/3 model, suggesting that N .509 may be the correct assumption. (Part of this uncertainty pertains to the actual mechanism of self-association, how a b-spiral would stabilize intermolecular interactions, and what the shapes of those oligomers might be. One could envision heterogeneous contacts between b-turns that preserve the extended structure of a proline-rich sequence like ELP. The CD data suggest other b-structures, but verification by other methods (e.g., Fourier transform infrared and laser Raman spectroscopy) is required.) Although the SV experiments proposed above on a family of IDPs would provide the data to determine the exact N v relationship, the additional feature that association might be linked to folding and compaction would also apply, and thus each system would require separate analysis. This reemphasizes the issue discussed above about fitting parameters coupling and the need at times to make assumptions about hydrodynamic and thermodynamic relationships rather than trusting the best-fitted values for an underdetermined system. Note that the uncertainty in K iso is estimated by Fstat analysis of parameter uncertainty (Table 4) , but, as discussed above, this does not include uncertainty in f/f 0 or s n values that couple with K iso .
One of the implicit assumptions in this work is that biophysical characterization of therapeutic molecules informs the development process. This is why many of the biotech companies that are developing therapeutic antibodies perform AUC analyses on their formulations and in plasma. Stability and aggregation are the two main issues being characterized (50, 51) . Our studies reveal that ELP is stable and undergoes weak reversible association in PBS. Additional studies characterizing ELP in FBS and as a function of serum components (albumin and g-globulin) will be presented elsewhere. One might ask whether the exact mechanism or model of ELP[V 5 G 3 A 2 -150]s assembly, aggregation, or solubility matters in terms of therapeutic development. For example, the idea of an ELP solubility constant has many similarities to the solubility of Hb-S, the hemoglobin variant found in sickle cell disease. Hb-S also exhibits a negative temperature coefficient of solubility, consistent with processes driven by hydrophobic interactions, and does not undergo a significant structural transition upon polymerization (52) . The stochastic nucleation of Hb-S involves the formation of a 14-strand nucleus, and much effort has been spent on developing small-molecule drugs that might inhibit this nucleation process. The discovery of an ELP Cc suggests that a more complex model involving nucleation or heterogeneous nucleation may also be appropriate, similar to Hb-S (52) and microtubule polymerization (53) . Understanding factors that affect localization and aggregation to a site of heating might improve the efficiency of this process while also minimizing nonspecific localization to other tissues or organs. At the very least, a quantitative model is required to interpret data collected in plasma, including bioavailability analysis. Furthermore, the role of elastin in the physiological environment as an elastic entropic spring is believed to depend on water release and hydrophobic collapse into a condensed b-spiral or b-structure (54). Future analyses are planned to examine the role of water and the hydrophobic effect in these weak interactions by repeating the sedimentation analyses while lowering the activity of water and varying the concentrations of additional serum components.
The turbidity data are consistent with previous observations, including the surprising impact of a small molecule such as fluorescein causing a 3.5 C decrease in T T (3), and suggests that these measurements need to be made on the drug complex and not just the delivery system. The analysis in FBS suggests that the properties of ELP[V 5 G 3 A 2 -150] are changed in the physiological buffer. The T T was found to increase by~2.2 C, which also emphasizes the need to examine the T T in the physiological buffer. To illustrate this, based on the T T in PBS, at 42 C 9.8 mM of ELP [V 5 G 3 A 2 -150] will circulate freely and not aggregate. In 95% FBS, however, 27.39 mM of ELP[V 5 G 3 A 2 -150] will circulate freely and not aggregate at 42 C. SV suggests that this increase in the T T can be attributed to association with serum proteins; however, no specific stable complexes are formed. These conclusions clearly have consequences for dosage and therapeutic delivery. This is the subject of separate studies involving CPP and drug-labeled ELP [V 5 G 3 A 2 -150] constructs. 
SUPPORTING MATERIAL
ELP Purification:
The protein purification method used was taken from (1). The sequence for the ELP1 polypeptide was constructed on pET25b+ vectors with a T7 promoter, then transformed into E. coli BLR(DE3) cells. The cells were grown in 0.5 liters of TB Dry media plus ampicillin (100 μg/mL) at 37°C with 220 rpm agitation for approximately 17 hours. Cells were isolated by centrifuging the cell culture for 15 minutes at 6,000 rpm, re-suspended in PBS+BME and lysed with 10-second bursts of sonication for 2 minutes. The solution was centrifuged at 13,000 rpm for 45 minutes to pellet the membranes and large organelles and the supernatant was collected. 1 mL of PEI was added to the supernatant to aggregate negatively charged soluble molecules and the solution was then centrifuged for 30 minutes at 13,000 rpm and the supernatant collected. The remaining solution was heated to 45°C to aggregate the ELP[V 5 G 3 A 2 -150] and centrifuged for 10 minutes at 10,000 rpm in a rotor that had been previously heated to at least 30°C in a water bath to pellet the aggregated ELP[V 5 G 3 A 2 -150]. The pelleted ELP[V 5 G 3 A 2 -150] was resuspended in PBS and remaining impurities were removed through repeated rounds of thermal cycling consisting of "hot" and "cold" spins. The "hot" spin removes soluble impurities by first heating the dissolved ELP[V 5 G 3 A 2 -150] in a water bath at 65°C and centrifuging the solution for 2 minutes at 13,000 rpm and room temperature to concentrate the ELP[V 5 G 3 A 2 -150], then discarding the supernatant and re-suspending the ELP[V 5 G 3 A 2 -150] in fresh buffer. The "cold" spin removes insoluble impurities by cooling a solution of ELP for approximately 20 minutes on ice, then centrifuging for 2 minutes at 13,000 rpm and room temperature. Concentration was determined through absorbance using a calculated molar extinction coefficient of 5690 M at 280 nm based upon the amino acid sequence (2) .
The purified protein was equilibrated into the buffer using the method of Penefsky (3). The columns were constructed by placing a frit in the bottom of a 5 cc syringe, then adding sephadex G50 fine in 0.01% NaAzide to approximately 5 mL volume. Three column volumes of buffer (15 mL) were passed over the column to appropriately equilibrate the buffer. The columns were then spun in a clinical centrifuge on speed 5 from 2 minutes, and the sample was carefully pipetted onto the top of the column. Due to dilution of sample during the column the samples were made up to be 25% more concentrated than the desired highest final concentration. The columns were then spun for 2 minutes and the solution collected and used for biophysical studies as described below.
Fluorescein labeling of ELP[V 5 G 3 A 2 -150]:
Purified ELP[V 5 G 3 A 2 -150] was diluted to 10 μM in 0.1 M NaCO 3 (pH 9). Fluorescein (5-Carboxyfluorescein succinimidyl ester) dissolved in DMSO was added to the reaction for a final concentration of 60 μM (Protein:Fluorescein ratio = 1:6) and the reaction was allowed to proceed for approximately 1 hour at room temperature. To approximate the impact of labeling with a small drug like taxol or doxorubicin, the reaction was allowed to produce approximately 1:1 binding. The reaction was then stopped by removing unlabeled fluorescein using a minimum of 4 thermal cycles, described in protein purification. No free fluorescein was observed, as indicated by the absence of a raised baseline in the AUC runs at 488 nm. Fluorescently labeled ELP was used in three experiments presented here, turbidity as a function of concentration and temperature, SV as a function of concentration and temperature, and SV in serum. A significant challenge with labeled protein is knowing the actual concentration. The fluorescein in this case absorbs significantly at 280 nm, 322 nm, and 496 nm ( Figure S3 ). These data can be calibrated to extract extinction coefficents for fluorescine at each wavelength and then those values used on a specific labeled sample to determine protein concentration. . This is consistent with the increase in association observed by SV especially if one assumes the weak association observed below T T produces species that can nucleate aggregation. A more extensive discussion of labeling issues will be presented as part of a subsequent study on quantitative analysis of the Johnston-Ogston effect in serum. 
Dynamic Light Scattering
Samples were prepared for the DLS, DSC, & Turbidity measurements by diluting the stock solutions to the final desired concentration in 1X PBS buffer at 2 mL volumes, then aliquoting the dilute sample for each experiment. Dilute ELP solutions were stored at 4°C, and then immediately before a DLS measurement, 1.5 mL of the dilute solution was placed in a conical tube and spun for approximately 5 minutes using a TOMY HF-120 Capsulefuge with an RCF of approximately 2000 G. Approximately 200 µl of the ELP sample was withdrawn from the conical centrifuge tube and used to overfill the 10 µl DLS quartz cuvette. All of these operations were done at 4°C. The DLS cuvette was examined to ensure that no air bubbles were present in the active volume, and the cell allowed to equilibrate for 5 minutes after being placed into the DLS instrument. Dynamic light scattering data were collected at 658 nm using a 10 s acquisition time with a DyanProTM NanoStar instrument (Wyatt Technology, CA). The event schedule was set so data were collected at 1°C interval from 20°C to 60°C. The DLS instrument was equilibrated for 2 minutes at each measurement temperature. The auto attenuation mode was disabled, the laser power was set to 50%, and the hydrodynamic radius values, R H , were analyzed using the regularization mode. Data analysis, calculation of the particle size distribution was performed using the DYNAMICS software package (v.7.1.0) included with the instrument. The particle size distribution is bimodal at all temperatures below the aggregation temperature. The smaller particle size (≈ 9 nm) typically represents more than 99% of the ELP mass in solution. The larger particles in solution below the transition temperature represent residual aggregated particles. The logarithm of the representative particle size was plotted as a function of temperature over the measurement temperature range and the transition temperatures estimated from the sharp break in Log R H in these plots. To average the DLS data, the data sets were divided into flat regions below and above the T T and the mean and SD for each phase were calculated and summarized in Table 2 .
Differential Scanning Calorimetry
DSC experiments were performed using a Microcal VP-DSC (Northampton, MA). DSC measurements were done at three different concentrations: 130, 260 and 390 µM. Both the DSC sample and reference cells were filled with approximately 0.5 ml of 1X PBS buffer for baseline experiments while the sample cell was refilled with 0.5 ml of the appropriate ELP solution for the actual experiments. DSC experiments were done over the temperature range of 283-343 K (10-70°C) at a scan rate of 60°C/h. Each experiment included three up-scans followed by a cooling scan to 10°C for a period of at least 5 minutes between up scans. Repeated heating scans were compared to determine the reversibility of the ELP phase transition. A sharp transition was observed at the transition temperature T T for each ELP sample. The transition enthalpy, ΔH, was determined by integration of the baseline corrected excess heat capacity signal over the temperature range from 10°C below the transition temperature to 10°C above the transition temperature (e.g. from 30°C to 50°C).
Circular Dichroism:
Circular dichroism data was collected in a Jasco 720 with a polyscience polytemp temperature controller using either a 1 mm or 0.1 mm path length cell adapted for temperature control. Data was collected on a single sample and the temperature was changed between scans. The temperature was allowed to equilibrate until it remained constant for three minutes before each data set was collected. Each data set is the average of three consecutive scans. The spectra were measured at 0.71 mg/mL (11.92 μM), 0.93 mg/mL (15.59 μM), 1.25 mg/mL (20.99 μM), mg/mL. All experiments were repeated with a Jasco Model PTC-423S Single Position Peltier attachment and the appropriate 0.1 mm path length cell in order to improve the data density and the clarity of Figure 3D .
Turbidity Data:
All turbidity data was collected in a Cary 100 Bio uv-vis spectrophotometer with an external peltier temperature controller and a 1 cm path-length cuvette. The temperature was monitored using a probe placed in a reference cuvette throughout the experiment. The temperature reported was verified by an external probe to examine the accuracy of the temperature reported over the entire temperature range (20°C to 60°C). Turbidity was collected on both buffer and sample and the buffer turbidity was subtracted from all scans. Temperature was raised and lowered at a rate of 1.0°C/minute from 20°C to 50°C to examine the reversibility of the aggregation process ( Figure 1A) , otherwise the aggregated sample would pellet to the bottom of the cuvette. Temperature was raised at a rate of 0.1°C/minute when the T T was measured ( Figure 1B and Figure 2 ). The T T was calculated by taking the first derivative of the turbidity vs temperature plot, and recording the highest value, or the greatest increase in turbidity with respect to temperature, as the T T . Our analysis indicates that the T T is related to ELPs solubility constant, which measures the concentration at which ELP first begins to aggregate. Therefore the C C was calculated by manually selecting the inflection point or first increase in turbidity with respect to temperature. The difference between choosing the inflection vs the point of greatest derivative was -0.14 o C (SD=0.05 N=19).
Buffer Density and Protein v-bar calculations:
The buffer densities were experimentally determined using an Anton Parr DMA 5000 density meter averaged over 5 measurements. The temperature was calibrated by the method of Li & Stafford (4) so that 5°C, 10°C, 20°C, 30°C, & 35°C corresponds to 4.62°C, 9.65°C, 19.69°C, 29.73, and 34.76°C, respectively. The v-bar, or partial specific volume, was estimated from the amino acid sequence (v = 0.7567; see Table 1 ) determined from the sequence of the DNA encoding the polypeptide using the software program SedNterp (2).
Analytical Ultracentrifugation (data collection & analysis):
All analytical ultracentrifugation (AUC) sedimentation velocity (SV) data were collected using a Beckman XL-A analytical ultracentrifuge that has been modified to include a fluorescence detection system (AU-FDS, AVIV Biomedical). Absorbance data were collected at 280 nm with a spacing of 0.02 cm and 1 scan in continuous scan mode. Fluorescence data were collected with a spacing of 20 μm averaging 5 scans. SV runs were typically done in 1.2 and 0.3 cm centerpieces for ABS measurements and 0.3 cm centerpieces for FDS measurements. Centerpiece assemblies utilized SedVel50 or SedVel60 designs from Spin Analytical, where the 3 mm centerpieces in FDS runs had their top face repositioned near the top of a traditional 12 mm centerpiece to facilitate proper focus depth of the FDS laser. Laser focus depth was determined on a typical sample, and not the five hole reference cell, to improve linearity of plateau data. FDS data collection did not require a reference solution so six samples can be run in a four hole rotor. The meniscus position in an FDS experiment is difficult to determine by inspection from the raw data. To establish its location we perform an Absorbance scan in intensity mode after the FDS run at the same speed and temperature and determine the meniscus positions from those scans. All g(s) (5) data were calculated using the software program DCDT 2+ (5, 6), c(s) data were calculated using the software program Sedfit (7) and direct boundary fitting (both individual runs and globally) was performed using the software program SedAnal (8) . The f/f 0 values were was calculated using the v-bar method implemented in the software program Sednterp (2). Data were plotted using the graphing software program Origin.
PONDR and Hydrophobicity analysis:
The sequence of ELP[V 5 G 3 A 2 -150] was analyzed using the software program PONDR to predict the amount of disorder in the polypeptide. The program predicts that the entire sequence will be disordered, with an average disorder prediction of 0.9902. The residue hydrophobicity is taken from Kyte & Doolittle (9) where residues are assigned a numerical value from -4. 
